US HB8399 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on September 25 2020 - 25% progression, died in committee
Action: 2020-09-25 - Referred to the House Committee on Ways and Means.
Pending: House Ways And Means Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 25 2020 - 25% progression, died in committee
Action: 2020-09-25 - Referred to the House Committee on Ways and Means.
Pending: House Ways And Means Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.
Title
End Taxpayer Subsidies for Drug Ads Act
Sponsors
| Rep. Abby Finkenauer [D-IA] | Rep. Elissa Slotkin [D-MI] | Rep. David Trone [D-MD] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-09-25 | House | Referred to the House Committee on Ways and Means. |
| 2020-09-25 | House | Introduced in House |
Same As/Similar To
SB73 (Same As) 2019-01-10 - Read twice and referred to the Committee on Finance.
SB1801 (Related) 2019-06-12 - Read twice and referred to the Committee on Finance.
SB1801 (Related) 2019-06-12 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/8399/all-info |
| Text | https://www.congress.gov/116/bills/hr8399/BILLS-116hr8399ih.pdf |
